765 related articles for article (PubMed ID: 16979009)
1. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
van Kimmenade RR; Januzzi JL; Ellinor PT; Sharma UC; Bakker JA; Low AF; Martinez A; Crijns HJ; MacRae CA; Menheere PP; Pinto YM
J Am Coll Cardiol; 2006 Sep; 48(6):1217-24. PubMed ID: 16979009
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
[TBL] [Abstract][Full Text] [Related]
3. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
[TBL] [Abstract][Full Text] [Related]
4. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
5. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
Meijers WC; de Boer RA; van Veldhuisen DJ; Jaarsma T; Hillege HL; Maisel AS; Di Somma S; Voors AA; Peacock WF
Eur J Heart Fail; 2015 Dec; 17(12):1271-82. PubMed ID: 26466857
[TBL] [Abstract][Full Text] [Related]
7. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
[TBL] [Abstract][Full Text] [Related]
8. Short-term mortality risk in emergency department acute heart failure.
Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
[TBL] [Abstract][Full Text] [Related]
10. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
11. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
13. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.
Baggish AL; Siebert U; Lainchbury JG; Cameron R; Anwaruddin S; Chen A; Krauser DG; Tung R; Brown DF; Richards AM; Januzzi JL
Am Heart J; 2006 Jan; 151(1):48-54. PubMed ID: 16368291
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
15. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
Baggish AL; van Kimmenade RR; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
18. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
19. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure.
Velibey Y; Golcuk Y; Golcuk B; Oray D; Atilla OD; Colak A; Kurtulmus Y; Erbay AR; Yilmaz A; Eren M
Am J Emerg Med; 2013 Dec; 31(12):1634-7. PubMed ID: 24055249
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
